The Rising Price of Drugs in the US скачать в хорошем качестве

The Rising Price of Drugs in the US

2023 UNC Business of Healthcare Conference Morning Keynote Panel: The Rising Price of Drugs in the US The escalating prices of many prescription drugs has been a focus area of US healthcare reform for the past decade, but the complexity around how drug list prices are set, who is reaping the benefits, and how those costs are passed on has come under closer scrutiny as of late. Rising drug prices place an immense financial burden on patients and is one of the primary drivers for higher healthcare spending in the US when compared to other OECD nations. This panel of experts will begin to address what causes rising drug prices in the US, explore potential and current policy solutions, and will discuss implications for patients and the ability to access and afford essential medications. Attendees can expect a robust discussion on the complex factors driving rising drug prices and potential pathways toward more affordable and equitable healthcare solutions. Moderator: Brad Staats, Faculty Director of the UNC Center for the Business of Health Panelists: Fauzea Hussain, Vice President of Public Policy at McKesson Amanda Forys, Partner at Magnolia Market Access Frances Nahas, Chief Strategy Officer at RedSail Technologies